Acrivon Therapeutics, Inc.'s total assets for Q4 2025 were $129.72M, a decrease of -10.72% from the previous quarter. ACRV total liabilities were $17.20M for the fiscal quarter, a 3.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.